Janus Contrarian Fund (JSVAX)

Investing Opportunistically in Non-Consensus Equity Ideas

SHARE CLASS

FUND FACTS (JSVAX)

Inception Date2/29/2000
NAV (As of 2/12/16 )$16.01
Total Net Assets (As of 12/31/15)$3.21B
Annual Expense Ratio
(As of fiscal year end 9/30/15)
GROSS 1.04%
NET 1.04%

Performance (As of 12/31/15)
1 Year-13.16%
3 Year12.17%
5 Year8.01%
10 Year5.79%
Morningstar (As of 1/31/16)
CategoryMid-Cap Blend
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/17.

Quarterly Commentary - Q4 2015

EXECUTIVE SUMMARY

U.S. equities notched gains in the period, but slow global economic growth and the prospect of rising rates in the U.S. were sources of concern for the market.

The Fund underperformed its benchmark during the period.

We continue to be encouraged about the fundamental improvements and changes taking place at the companies in our Fund.

FUND MANAGEMENT

Dan Kozlowski

Daniel R. Kozlowski, CFA

Fund Manager since 2011
Industry since 1999